Hannah Melchinger

443 total citations
11 papers, 280 citations indexed

About

Hannah Melchinger is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Hannah Melchinger has authored 11 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Nephrology, 4 papers in Cardiology and Cardiovascular Medicine and 2 papers in Surgery. Recurrent topics in Hannah Melchinger's work include Chronic Kidney Disease and Diabetes (4 papers), Heart Failure Treatment and Management (2 papers) and Medication Adherence and Compliance (2 papers). Hannah Melchinger is often cited by papers focused on Chronic Kidney Disease and Diabetes (4 papers), Heart Failure Treatment and Management (2 papers) and Medication Adherence and Compliance (2 papers). Hannah Melchinger collaborates with scholars based in United States, Australia and China. Hannah Melchinger's co-authors include John Hwa, Tarun Tyagi, Kanika Jain, F. Perry Wilson, Henry M. Rinder, Wai Ho Tang, Chirag R. Parikh, Miaoyun Qiu, Melissa Shaw and Elizabeth E. Gardiner and has published in prestigious journals such as Nature Communications, Clinical Journal of the American Society of Nephrology and JACC Heart Failure.

In The Last Decade

Hannah Melchinger

10 papers receiving 279 citations

Peers

Hannah Melchinger
Hannah Melchinger
Citations per year, relative to Hannah Melchinger Hannah Melchinger (= 1×) peers Hisaki Shimada

Countries citing papers authored by Hannah Melchinger

Since Specialization
Citations

This map shows the geographic impact of Hannah Melchinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hannah Melchinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hannah Melchinger more than expected).

Fields of papers citing papers by Hannah Melchinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hannah Melchinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hannah Melchinger. The network helps show where Hannah Melchinger may publish in the future.

Co-authorship network of co-authors of Hannah Melchinger

This figure shows the co-authorship network connecting the top 25 collaborators of Hannah Melchinger. A scholar is included among the top collaborators of Hannah Melchinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hannah Melchinger. Hannah Melchinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Melchinger, Hannah, Saad B. Omer, & Amyn A. Malik. (2025). Change in confidence in public health entities among US adults between 2020–2024. PLOS Global Public Health. 5(6). e0004747–e0004747. 1 indexed citations
2.
Melchinger, Hannah, et al.. (2025). Change in influenza vaccine uptake among adults in the United States from May 2020 to October 2024. PLOS Global Public Health. 5(7). e0004756–e0004756.
3.
Wilson, F. Perry, Yu Yamamoto, Melissa Martin, et al.. (2023). A randomized clinical trial assessing the effect of automated medication-targeted alerts on acute kidney injury outcomes. Nature Communications. 14(1). 2826–2826. 20 indexed citations
4.
Martin, Melissa L., Yu Yamamoto, Hannah Melchinger, et al.. (2023). Impact of Digital Health Technology on Quality of Life in Patients With Heart Failure. JACC Heart Failure. 12(2). 336–348. 14 indexed citations
5.
Melchinger, Hannah, Jason Weinstein, Melissa Shaw, et al.. (2022). Urine testing to differentiate glomerular from tubulointerstitial diseases on kidney biopsy. Practical Laboratory Medicine. 30. e00271–e00271. 5 indexed citations
6.
Melchinger, Hannah, et al.. (2022). Wearables in Cardiovascular Disease. Journal of Cardiovascular Translational Research. 16(3). 557–568. 15 indexed citations
7.
Martin, Melissa, Yu Yamamoto, Tariq Ahmad, et al.. (2022). Pragmatic randomized trial assessing the impact of digital health technology on quality of life in patients with heart failure: Design, rationale and implementation. Clinical Cardiology. 45(8). 839–849. 6 indexed citations
8.
Tyagi, Tarun, Kanika Jain, Sean X. Gu, et al.. (2022). A guide to molecular and functional investigations of platelets to bridge basic and clinical sciences. Nature Cardiovascular Research. 1(3). 223–237. 50 indexed citations
9.
Menez, Steven, Jason Weinstein, Hannah Melchinger, et al.. (2022). Safety and Adequacy of Kidney Biopsy Procedure in Patients with Obesity. Kidney360. 4(1). 98–101. 2 indexed citations
10.
Melchinger, Hannah, Wassim Obeid, Leyuan Xu, et al.. (2022). Urine Uromodulin as a Biomarker of Kidney Tubulointerstitial Fibrosis. Clinical Journal of the American Society of Nephrology. 17(9). 1284–1292. 28 indexed citations
11.
Melchinger, Hannah, Kanika Jain, Tarun Tyagi, & John Hwa. (2019). Role of Platelet Mitochondria: Life in a Nucleus-Free Zone. Frontiers in Cardiovascular Medicine. 6. 153–153. 139 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026